From company acquisitions to FDA nods, here are six key updates in orthobiologics since Oct. 4.
1. RTI Surgical, a healthcare biologics company, plans to acquire Collagen Solutions.
2. Tetrous, a start-up focused on bone-to-tendon healing following orthopedic surgery, has earned a fourth patent related to its EnFix family of demineralized cortical bone fiber implants.
3. Bone Biologics appointed Phillip Meikle to its board of directors.
4. CytexOrtho has earned FDA approval to begin a clinical trial evaluating the safety and efficacy of its absorbable hip implant in human patients.
5. Biologics company Theradaptive's lead therapeutic, OsteoAdapt SP, has been featured in a preclinical spinal fusion study published in Spine, a prominent, peer-reviewed publication for spinal surgeons.
6. Acuitive Technologies earned FDA clearance for the Citrepore bioactive bone filler.